Elevance Health Statistics
Total Valuation
Elevance Health has a market cap or net worth of $69.76 billion. The enterprise value is $91.24 billion.
Important Dates
The next estimated earnings date is Thursday, October 16, 2025, before market open.
| Earnings Date | Oct 16, 2025 |
| Ex-Dividend Date | Sep 10, 2025 |
Share Statistics
Elevance Health has 225.18 million shares outstanding. The number of shares has decreased by -2.43% in one year.
| Current Share Class | 225.18M |
| Shares Outstanding | 225.18M |
| Shares Change (YoY) | -2.43% |
| Shares Change (QoQ) | -0.62% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 92.55% |
| Float | 224.67M |
Valuation Ratios
The trailing PE ratio is 13.25 and the forward PE ratio is 10.00. Elevance Health's PEG ratio is 1.94.
| PE Ratio | 13.25 |
| Forward PE | 10.00 |
| PS Ratio | 0.37 |
| Forward PS | 0.34 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 18.02 |
| P/FCF Ratio | 13.04 |
| P/OCF Ratio | 10.79 |
| PEG Ratio | 1.94 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.62, with an EV/FCF ratio of 17.10.
| EV / Earnings | 17.02 |
| EV / Sales | 0.48 |
| EV / EBITDA | 9.62 |
| EV / EBIT | 10.44 |
| EV / FCF | 17.10 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.44 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 5.66 |
| Interest Coverage | 6.60 |
Financial Efficiency
Return on equity (ROE) is 12.42% and return on invested capital (ROIC) is 7.45%.
| Return on Equity (ROE) | 12.42% |
| Return on Assets (ROA) | 4.65% |
| Return on Invested Capital (ROIC) | 7.45% |
| Return on Capital Employed (ROCE) | 11.19% |
| Revenue Per Employee | $1.82M |
| Profits Per Employee | $51,440 |
| Employee Count | 104,200 |
| Asset Turnover | 1.61 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Elevance Health has paid $1.72 billion in taxes.
| Income Tax | 1.72B |
| Effective Tax Rate | 24.32% |
Stock Price Statistics
The stock price has decreased by -43.12% in the last 52 weeks. The beta is 0.59, so Elevance Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -43.12% |
| 50-Day Moving Average | 320.90 |
| 200-Day Moving Average | 380.96 |
| Relative Strength Index (RSI) | 52.26 |
| Average Volume (20 Days) | 2,338,797 |
Short Selling Information
The latest short interest is 3.16 million, so 1.40% of the outstanding shares have been sold short.
| Short Interest | 3.16M |
| Short Previous Month | 2.72M |
| Short % of Shares Out | 1.40% |
| Short % of Float | 1.41% |
| Short Ratio (days to cover) | 0.99 |
Income Statement
In the last 12 months, Elevance Health had revenue of $189.25 billion and earned $5.36 billion in profits. Earnings per share was $23.39.
| Revenue | 189.25B |
| Gross Profit | 50.79B |
| Operating Income | 8.74B |
| Pretax Income | n/a |
| Net Income | 5.36B |
| EBITDA | 9.49B |
| EBIT | 8.74B |
| Earnings Per Share (EPS) | $23.39 |
Full Income StatementBalance Sheet
The company has $34.79 billion in cash and $30.19 billion in debt, giving a net cash position of -$21.63 billion or -$96.04 per share.
| Cash & Cash Equivalents | 34.79B |
| Total Debt | 30.19B |
| Net Cash | -21.63B |
| Net Cash Per Share | -$96.04 |
| Equity (Book Value) | 43.85B |
| Book Value Per Share | 194.46 |
| Working Capital | 19.49B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $6.45 billion and capital expenditures -$1.12 billion, giving a free cash flow of $5.34 billion.
| Operating Cash Flow | 6.45B |
| Capital Expenditures | -1.12B |
| Free Cash Flow | 5.34B |
| FCF Per Share | $23.70 |
Full Cash Flow StatementMargins
Gross margin is 26.84%, with operating and profit margins of 4.62% and 2.83%.
| Gross Margin | 26.84% |
| Operating Margin | 4.62% |
| Pretax Margin | 3.73% |
| Profit Margin | 2.83% |
| EBITDA Margin | 5.01% |
| EBIT Margin | 4.62% |
| FCF Margin | 2.82% |
Dividends & Yields
This stock pays an annual dividend of $6.84, which amounts to a dividend yield of 2.21%.
| Dividend Per Share | $6.84 |
| Dividend Yield | 2.21% |
| Dividend Growth (YoY) | 6.12% |
| Years of Dividend Growth | 14 |
| Payout Ratio | 28.91% |
| Buyback Yield | 2.43% |
| Shareholder Yield | 4.64% |
| Earnings Yield | 7.70% |
| FCF Yield | 7.67% |
Dividend DetailsAnalyst Forecast
The average price target for Elevance Health is $411.86, which is 32.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $411.86 |
| Price Target Difference | 32.94% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 14.37% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on June 1, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
